Illumina Inc (ILMN)
LABORATORY ANALYTICAL INSTRUMENTS
- Headquarters
- United States
- Employees
- 8,650
- Market Cap
- $31.0B
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
SentiSense also tracks daily options readings for Illumina Inc: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Illumina Inc stock analysis, sentiment tracking, and market intelligence on SentiSense.